Rebiotix Revenue and Competitors
Estimated Revenue & Valuation
- Rebiotix's estimated annual revenue is currently $27.9M per year.
- Rebiotix received $8.5M in venture funding in September 2017.
- Rebiotix's estimated revenue per employee is $193,750
- Rebiotix's total funding is $39.1M.
Employee Data
- Rebiotix has 144 Employees.
- Rebiotix grew their employee count by 13% last year.
Rebiotix's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Clinical Recruitment | Reveal Email/Phone |
2 | VP Finance & Operations | Reveal Email/Phone |
3 | Head Regulatory Affairs | Reveal Email/Phone |
4 | VP, Global Early-Stage Commercialization and Market Strategy (Microbiome Franchise) | Reveal Email/Phone |
5 | head clinical development | Reveal Email/Phone |
6 | Associate Director Clinical Operations | Reveal Email/Phone |
7 | Sr. Director Quality | Reveal Email/Phone |
8 | Associate Director, Global Upstream Marketing and Communications | Reveal Email/Phone |
9 | Director Production, Engineering and Technical Services | Reveal Email/Phone |
10 | Chief Operating Officer | Reveal Email/Phone |
Rebiotix Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.8M | 50 | 9% | N/A | N/A |
#2 | $7.4M | 48 | -35% | N/A | N/A |
#3 | $0.9M | 6 | 20% | N/A | N/A |
#4 | $0.3M | 2 | -91% | N/A | N/A |
#5 | $3.6M | 23 | 5% | N/A | N/A |
#6 | $0.9M | 6 | -33% | N/A | N/A |
#7 | $5M | 32 | 3% | N/A | N/A |
#8 | $14.7M | 95 | 9% | N/A | N/A |
#9 | $14.7M | 95 | 0% | $20.5M | N/A |
#10 | $27.9M | 144 | 13% | $39.1M | N/A |
What Is Rebiotix?
Rebiotix Inc is a clinical-stage biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the power of the human microbiome. Our highly skilled and dynamic team is based out of Roseville, Minnesota. Please feel free to contact us through our website at www.rebiotix.com.
keywords:Biotechnology,Healthcare,Pharmaceuticals
$39.1M
Total Funding
144
Number of Employees
$27.9M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Rebiotix News
A stool-based enema composed of a broad variety of microbes (RBX2660, Rebiotix/Ferring) was up to 84% effective in reducing recurrent Clostridioides...
RBX2660 (Rebiotix); SER-109 (Seres Therapeutics); CP-101 (Finch Therapeutics); VE303 (Vedanta Biosciences); NTCD M3 (Destiny Pharmaceuticals)...
The project, comprising mixed bacterial consortia, was originated by Rebiotix, a US biotech that Ferring bought in 2018.
ROSEVILLE, Minn.--(BUSINESS WIRE)-- Rebiotix Inc, a Ferring Pharmaceuticals company, announced today that their Chief Scientific Officer, ...
Other Companies in Roseville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $25.8M | 144 | 6% | N/A |
#2 | $63.4M | 144 | 7% | N/A |
#3 | $7.5M | 146 | N/A | N/A |
#4 | $16.3M | 148 | 1% | N/A |
#5 | $15M | 148 | 10% | N/A |
Rebiotix Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2014-07-11 | $18.0M | Undisclosed | Article | |
| 2014-08-05 | $25.0M | B | Article | |
| 2017-09-08 | $8.5M | Undisclosed | Article |